Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
NS3
protein of hepatitis C virus is a multifunctional protein that is indispensable for virus replication. Little is known, however, about the possible effects of the
NS3
on host cell function(s). In the present study, we demonstrated that NIH3T3 cells constitutively expressing a carboxy-terminally truncated
NS3
(NS3DeltaC) were more resistant to actinomycin D-induced apoptosis than the control cells. We also observed that induction of
p53
expression by actinomycin D treatment was weaker in the NS3DeltaC-expressing cells than in the control cells. However, induction of WAF1 expression by the same treatment was not different between the two groups. Taken together, our results suggest the possibility that expression of NS3DeltaC suppressed actinomycin D-induced apoptosis of NIH3T3 cells through at least partly, if not solely, a
p53
-dependent, WAF1-independent pathway.
...
PMID:Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. 895 79
By using vaccinia virus-T7 hybrid expression system, subcellular localization of the
NS3
protein of hepatitis C virus was studied. Full-size
NS3
(NS3F) and a carboxy-terminally truncated form (
NS3
deltaC) were localized in the cytoplasm and the nucleus when expressed alone. However, NS3F and
NS3
deltaC, but not amino- and carboxy-terminally truncated form (
NS3
deltaN deltaC), were each co-localized with wild-type
p53
almost exclusively in the nucleus upon co-expression. The wild-type
p53
-induced nuclear accumulation of NS3F was inhibited only partially by NS4A. When co-expressed with mutant-type
p53
, NS3F and
NS3
deltaC were each co-localized with it exclusively in the cytoplasm. Taken together, the present results suggest that wild-type
p53
enhances nuclear accumulation of NS3F and
NS3
deltaC through the involvement of their amino-terminal sequences even in the presence of NS4A, and that mutant-type
p53
inhibits their nuclear, and enhances their cytoplasmic, accumulation.
...
PMID:Wild-type, but not mutant-type, p53 enhances nuclear accumulation of the NS3 protein of hepatitis C virus. 901 97
Subcellular localization of the NS2 and
NS3
proteins of hepatitis C virus was analyzed. In stable Ltk transfectants inducibly expressing an NS2-
NS3
polyprotein (amino acids [aa] 810 to 1463), processed full-size NS2 (aa 810 to 1026) was detected exclusively in a cytoplasmic membrane fraction. On the other hand, the other processed product, carboxy-truncated
NS3
(
NS3
deltaC1463; aa 1027 to 1463), was present in both cytoplasmic and nuclear fractions. To further analyze subcellular localization of
NS3
,
NS3
deltaC1459 (aa 1027 to 1459), full-size
NS3
(NS3F; aa 1027 to 1657), and both amino- and carboxy-truncated
NS3
(
NS3
deltaNdeltaC; aa 1201 to 1459) were expressed in HeLa cells by using a vaccinia virus-T7 hybrid expression system.
NS3
deltaC1459 and NS3F accumulated in the nucleus as well as in the cytoplasm, exhibiting a dot-like staining pattern. On the other hand,
NS3
deltaNdeltaC was localized predominantly in the cytoplasm, suggesting the presence of a nuclear localization signal(s) in the amino-terminal sequence of
NS3
. NS4A, a viral cofactor for the
NS3
protease, inhibited nuclear transport of
NS3
deltaC1459 and NS3F, with the latter inhibited to a lesser extent than was the former. Interestingly, wild-type
p53 tumor suppressor
augmented nuclear localization of
NS3
deltaC1459 and NS3F, whereas mutant-type
p53
inhibited nuclear localization and augmented cytoplasmic localization of
NS3
deltaC1459. However, subcellular localization of
NS3
deltaNdeltaC was not affected by either type of
p53
. Wild-type
p53
-mediated nuclear accumulation of
NS3
deltaC1459 and NS3F was inhibited partially, but not completely, by coexpressed NS4A, with NS3F again affected less prominently than was
NS3
deltaC1459.
...
PMID:Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. 918 58
By co-immunoprecipitation analysis, we demonstrated that wt-
p53
formed a complex with non-structural protein (NS) 3 of hepatitis C virus, both in the absence and the presence of NS4A, a viral cofactor that strongly associates with
NS3
. Deletional analysis revealed that a portion near the N-terminus of
NS3
(amino acids (aa) 1055 and 1200), which is different from the NS4A binding site, was necessary for the complex formation with wt-
p53
. On the other hand, a portion near the C-terminus of wt-
p53
(aa 301-360), which has been reported to contain the oligomerization domain, was important for the complex formation with
NS3
.
...
PMID:Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. 982 57
Hepatitis C virus (HCV) causes a persistent infection, chronic hepatitis, and hepatocellular carcinoma. Since there are several reports indicating that some viruses influence the
tumor suppressor p53
function, we determined the effects of HCV proteins on
p53
function and its mechanism determined by use of a reporter assay. Among seven HCV proteins investigated (core, NS2,
NS3
, NS4A, NS4B, NS5A, and NS5B), only core protein augmented the transcriptional activity of
p53
and increased the expression of p21(waf1) protein, which is a major target of
p53
. Core protein increased both DNA-binding affinity of
p53
in electrophoretic morbidity shift assay and transcriptional ability of
p53
itself in a reporter assay. The direct interaction between core protein and C terminus of
p53
was also shown by glutathione S-transferase fusion protein binding assay. In addition, core protein interacted with hTAF(II)28, a component of the transcriptional factor complex in vivo and in vitro. These results suggest that HCV core protein interacts with
p53
and modulates
p53
-dependent promoter activities during HCV infection.
...
PMID:Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. 1092 97
Hepatitis C virus (HCV)
NS3
protein is known to affect normal cellular functions, such as cell proliferation and cell death, and to be involved, either directly or indirectly, in HCV hepatocarcinogenesis. In this study, we demonstrated that
NS3
protein could specifically repress the promoter activity of p21 in a dose-dependent manner. The effect was not cell type-specific and was synergistic when combined with HCV core protein. Repression of the p21 promoter by
NS3
was almost completely lost when
p53
binding sites present on the p21 promoter were removed. Furthermore,
p53
binding sites were sufficient to confer a strong
NS3
responsiveness to an heterologous promoter, suggesting that
NS3
represses the transcription of p21 by modulating the activity of
p53
. Although the
NS3
protein domain required for the majority of p21 repression was located on the protease domain, the proteinase activity itself does not seem to be necessary for repression. Both transcription and protein stability of
p53
were unaffected by
NS3
, suggesting that
NS3
might repress transcription of p21 by inhibiting the regulatory activity of
p53
via protein-protein interaction(s). Finally, the growth rate of
NS3
-expressing cell lines was at least twice as fast as that of the parent NIH 3T3 cells, indicating that the repression of p21 is actually reflected by the stimulation of cell growth.
...
PMID:p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3. 1151 34
AIM:To study hepatocarcinogenesis of hepatitis C virus (HCV).METHODS: Expression of HCV antigens (CP10,
NS3
and NS5) and several cancer-associated gene products (ras p21, c-myc, c-erbB-2, mutated
p53
and p16 protein) in the tissues of hepatocellular carcinoma (HCC, n = 46) and its surrounding liver tissue were studied by the ABC(avidin-biotin complex) immunohistochemical method. The effect of HCV infection on expression of those gene products in HCC was analyzed by comparing HCV antigen positive group with HCV antigen negative group.RESULTS:Positive immunostaining with one, two or three HCV antigens was found in 20 (43.5%) cases,with either of two or three HCV antigens in 16 (34.8%) cases, and with three HCV antigens in 9 (19.6%) cases.Deletion rate of p16 protein expression in HCC with positive HCV antigen (80%, 16/20)was significantly higher than that in HCC with negative HCV antigen. Whereas no significant difference of the other gene product expression was observed between the two groups.CONCLUSION:HCV appears related to about one third of cases of HCC in Chongqing, the southwest of China, and it may be involved in hepatocarcinogenesis by inhibi ting the function of p16 gene, which acts as a negative regulator of cell cycle.
...
PMID:Effect of HCV infection on expression of several cancer-associated gene products in HCC. 1181 78
Possible inhibitory effects of hepatitis C virus (HCV) proteins on cellular protein synthesis were analyzed using transient expression system. The core protein, the nonstructural protein 4A (NS4A) and NS4B, but not
NS3
, NS5A or NS5B, inhibited p21/Waf1 expression post-transcriptionally. Further analysis revealed that the inhibition by NS4A and NS4B was mediated at least partly, if not entirely, at the translation level. NS4A-mediated translational inhibition was counteracted to some extent by
NS3
co-expressed either in trans or cis. Co-expression of NS4A and NS4B exerted an additive effect on the translational inhibition. The N-terminal two-thirds of NS4A (amino acids 1-40) was shown to be involved in the translational inhibition. We also tested possible inhibitory effects of NS4A and NS4B on synthesis of other cellular proteins in parallel with p21/Waf1. NS4A and NS4B inhibited p21/Waf1 most strongly, followed by RNase L,
p53
, a C-terminally truncated form of CREB-RP and 2'-5' oligoadenylate synthetase. p21/Waf1, RNase L and
p53
are known to have the PEST (proline-glutamic acid-serine-threonine) motif with relatively high scores in their sequences and considered to be sensitive to intracellular degradation. Taken together, our results suggest that NS4A and NS4B each mediate translational inhibition and, probably, increased degradation of certain cellular proteins.
...
PMID:Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus. 1245 68
Several reports have shown that activity and/or expression of
p53
can be modulated by Hepatitis C virus (HCV) proteins and may interfere with normal regulation of cell growth. In order to understand the relationship between
p53
function and HCV proteins expression, we have investigated potential effects of the core,
NS3
, NS5A and NS5B proteins on Huh-7 (
p53
+/+) and Hep3B (
p53
-/-) cell proliferation. The effect of HCV proteins transiently expressed after recombinant-adenoviral infection was analyzed by Western blot, crystal violet and propidium iodide staining. Expression of the core,
NS3
, NS5A or NS5B proteins inhibited cell proliferation and blocked both cell lines in the G2/M phase of the cell cycle. c-myc and
p53
expression were respectively induced and increased in Huh-7 cells only following expression of the Core protein. No expression of p21(waf1/cip1) could be detected and expression of cyclin A, cdk2 and p27(Kip1) were independent of HCV protein's expression. Our results show that the effect of core,
NS3
, NS5A and NS5B on cell proliferation is independent of
p53
expression and that only the Core protein, induces the expression of both c-myc and
p53
.
...
PMID:HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines. 1474 98
Hepatocellular carcinoma (HCC) is the most important primary hepatic cancer and is a common cancer type worldwide. Many aetiological factors have been related to HCC development, such as liver cirrhosis, hepatitis viruses and alcohol consumption. Inactivation of the
p53
tumour suppressor gene is one of the most common abnormalities in many tumours, including HCC.
p53
is of crucial importance for the regulation of the cell cycle and the maintenance of genomic integrity. In HCC, hepatitis B and C virus (HBV and HCV) effect carcinogenic pathways, independently leading to anomalies in
p53
function. Several authors have reported that some HCV proteins, such as the core, NS5A and
NS3
proteins, interact with
p53
and prevent its correct function. The mechanisms of action of these HCV proteins in relation to
p53
are not completely clear, but they might cause its cytoplasmic retention or accumulation in the perinuclear region where the protein is not functional. The identification of the interactions between
p53
and HCV proteins is of great importance for therapeutic strategies aimed at reducing the chronicity and/or carcinogenicity of the virus.
...
PMID:Hepatocellular carcinoma: molecular interactions between hepatitis C virus and p53 in hepatocarcinogenesis. 1498 3
1
2
Next >>